WallStSmart

Covista Inc. (CVSA)vsStride Inc (LRN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Stride Inc generates 29% more annual revenue ($2.52B vs $1.95B). LRN leads profitability with a 13.4% profit margin vs 12.9%. LRN appears more attractively valued with a PEG of 0.46. LRN earns a higher WallStSmart Score of 71/100 (B).

CVSA

Strong Buy

71

out of 100

Grade: B

Growth: 8.0Profit: 7.5Value: 7.0Quality: 6.5
Piotroski: 4/9Altman Z: 3.05

LRN

Strong Buy

71

out of 100

Grade: B

Growth: 6.7Profit: 7.5Value: 8.7Quality: 8.5
Piotroski: 4/9Altman Z: 4.25
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for CVSA.

LRNUndervalued (+6.9%)

Margin of Safety

+6.9%

Fair Value

$88.16

Current Price

$78.90

$9.26 discount

UndervaluedFair: $88.16Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CVSA5 strengths · Avg: 8.4/10
Altman Z-ScoreHealth
3.0510/10

Safe zone — low bankruptcy risk

PEG RatioValuation
0.948/10

Growing faster than its price suggests

P/E RatioValuation
17.0x8/10

Attractively priced relative to earnings

Price/BookValuation
3.0x8/10

Reasonable price relative to book value

EPS GrowthGrowth
43.2%8/10

Earnings expanding 43.2% YoY

LRN5 strengths · Avg: 9.6/10
PEG RatioValuation
0.4610/10

Growing faster than its price suggests

P/E RatioValuation
11.5x10/10

Attractively priced relative to earnings

EPS GrowthGrowth
69.6%10/10

Earnings expanding 69.6% YoY

Altman Z-ScoreHealth
4.2510/10

Safe zone — low bankruptcy risk

Price/BookValuation
2.0x8/10

Reasonable price relative to book value

Areas to Watch

CVSA0 concerns · Avg: 0/10

No major concerns identified

LRN1 concerns · Avg: 2.0/10
Revenue GrowthGrowth
-2.7%2/10

Revenue declined 2.7%

Comparative Analysis Report

WallStSmart Research

Bull Case : CVSA

The strongest argument for CVSA centers on Altman Z-Score, PEG Ratio, P/E Ratio. PEG of 0.94 suggests the stock is reasonably priced for its growth.

Bull Case : LRN

The strongest argument for LRN centers on PEG Ratio, P/E Ratio, EPS Growth. PEG of 0.46 suggests the stock is reasonably priced for its growth.

Bear Case : CVSA

No major red flags identified for CVSA, but monitor valuation.

Bear Case : LRN

The primary concerns for LRN are Revenue Growth.

Key Dynamics to Monitor

CVSA profiles as a value stock while LRN is a declining play — different risk/reward profiles.

CVSA carries more volatility with a beta of 0.63 — expect wider price swings.

CVSA is growing revenue faster at 9.7% — sustainability is the question.

LRN generates stronger free cash flow (294M), providing more financial flexibility.

Bottom Line

CVSA scores higher overall (71/100 vs 71/100). Both earn "Strong Buy" and "Strong Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Covista Inc.

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA

Covista Inc., provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. The company is headquartered in Chicago, Illinois.

Stride Inc

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA

Stride, Inc., a technology-based education company, provides its own and third-party online educational services, software systems and curricula to facilitate individualized learning for students primarily in kindergarten through grade 12 (K -12) in the United States and internationally. .

Visit Website →

Want to dig deeper into these stocks?